Inici › Càncer de pròstata › Florida › Miami
Assaigs clínics de Càncer de pròstata a Miami, FL
27 estudis de Càncer de pròstata busquen participants en centres de Miami i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutantFase 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Precise Oncology Interventions in Nutrition and Training (OnPoint)
ReclutantVoluntaris sans benvinguts
- University of Miami, Miami
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
ReclutantFase 2/3
- Baptist Health South, Miami
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
ReclutantFase 3
- Baptist Health South, Miami
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
ReclutantFase 1
- Biogenix Molecular, LLC, Miami
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Reclutant
- University of Miami, Miami
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
ReclutantFase 3
- Biogenix Molecular, LLC, Miami
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
ReclutantFase 1/2
- Research Site, Miami
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
ReclutantFase 3
- Research Site, Miami
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
ReclutantFase 1/2
- Mount Sinai Medical Center, Miami
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ReclutantFase 2
- Biogenix Molecular, LLC, Miami
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
ReclutantFase 2
- Miami Cancer Institute at Baptist Health, Inc., Miami
PSMA PET Combined With MRI for the Detection of PCa
ReclutantFase 3Voluntaris sans benvinguts
- University of Miami, Miami
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutantFase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
ReclutantFase 1
- Sylvester Comprehensive Cancer Center, Miami
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
ReclutantFase 2
- University of Miami, Miami
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
ReclutantFase 1/2
- Biogenix Molecular LLC, Miami
- NovaCure Health, Miami
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
ReclutantFase 1
- Research Site, Miami
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
ReclutantEstudi observacionalVoluntaris sans benvinguts
- University of Miami, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ReclutantFase 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
Reclutant
- University of Miami, Miami
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
ReclutantEstudi observacional
- University of Miami, Miami
The University of Miami Adapt (UAdapt) Trial
ReclutantFase 2
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutantFase 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Miami Cancer Institute, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Miami
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ReclutantFase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Assaigs de Càncer de pròstata en altres ciutats
- New York City, NY103 estudis
- Houston, TX76 estudis
- Los Angeles, CA61 estudis
- Boston, MA59 estudis
- St. Louis, MO46 estudis
- Chicago, IL45 estudis
- San Francisco, CA45 estudis
- Philadelphia, PA44 estudis
- Baltimore, MD43 estudis
- Nashville, TN42 estudis
- Seattle, WA42 estudis
- Washington, DC38 estudis
Altres estudis a Miami
- Càncer de mama42 estudis
- Càncer (tots els tipus)36 estudis
- Càncer de pulmó de cèl·lules no petites31 estudis
- Obesitat27 estudis
- Leucèmia mieloide aguda24 estudis
- Càncer metastàtic24 estudis
- Càncer d'ovari23 estudis
- Sobrepès23 estudis
- Mieloma múltiple21 estudis
- Colitis ulcerosa21 estudis
- Malaltia d'Alzheimer20 estudis
- Càncer de pulmó20 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.